Literature DB >> 7462632

Delayed, relapsing experimental allergic encephalomyelitis in mice.

F D Lublin, P H Maurer, R G Berry, D Tippett.   

Abstract

Immunization of female SJL mice with an emulsion of lyophilized mouse spinal cord, pertussis vaccine, and complete Freund's adjuvant produces a delayed and often relapsing form of experimental allergic encephalomyelitis (DR-EAE). The mice develop initial signs of disease an average of 6 mo after immunization. Relapses occurred 2 wk to 11 mo after the initial illness. Some animals had multiple relapses. Pathologic examination of the brain and spinal cord revealed perivascular infiltration of mononuclear cells with acute demyelination. Areas of subacute and chronic demyelination ("plaques") were also seen. This model produces a clinical course of relapsing-remitting disease with pathologic evidence of both recent and old inflammatory lesions at various levels of the central nervous system. It thus more closely resembles multiple sclerosis than acute EAE.

Entities:  

Mesh:

Year:  1981        PMID: 7462632

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

2.  In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.

Authors:  L Steinman; J T Rosenbaum; S Sriram; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

3.  Characteristics of initial and reinduced experimental autoimmune encephalomyelitis.

Authors:  J W Lindsey
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; H Ovadia; R Mizrachi-Koll; A Ben-Nun; O Abramsky; S Slavin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 5.  Mitoxantrone: a review of its use in multiple sclerosis.

Authors:  Lesley J Scott; David P Figgitt
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice.

Authors:  R Korngold; A Feldman; L B Rorke; F D Lublin; P C Doherty
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

7.  Experimental autoimmune myositis in SJL/J mice.

Authors:  N L Rosenberg; S P Ringel; B L Kotzin
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

8.  Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

Authors:  D M Karussis; D Lehmann; S Slavin; U Vourka-Karussis; R Mizrachi-Koll; H Ovadia; T Kalland; O Abramsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

9.  Relapsing experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice.

Authors:  F D Lublin; R L Knobler; P C Doherty; R Korngold
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

10.  Does delay in acquiring childhood infection increase risk of multiple sclerosis?

Authors:  M Alter; Z Zhen-xin; Z Davanipour; E Sobel; S Min Lai; L LaRue
Journal:  Ital J Neurol Sci       Date:  1987-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.